4//SEC Filing
CLARKE JOHN K 4
Accession 0001209191-23-031002
CIK 0001339970other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:23 PM ET
Size
5.5 KB
Accession
0001209191-23-031002
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
CLARKE JOHN K
DirectorOther
Transactions
- Award
Stock Option (right to buy)
2023-05-17+12,000→ 12,000 totalExercise: $2.52Exp: 2033-05-17→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001219015
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:23 PM ET
- Size
- 5.5 KB